Lilly and NVIDIA launch AI co-innovation lab to tackle drug discovery challenges.NVIDIA collaborates with Thermo Fisher to ...

Expanded our physical footprint to 20 major cities and integrated 50%+ new experiences. TORONTO, ON AND NEW YORK, NY / ...

At the J.P. Morgan Healthcare Conference, Nvidia announced major AI partnerships with Lilly and Thermo Fisher Scientific to ...

Eli Lilly and Nvidia, two primary drivers of the recent stock market rally, are deepening their alliance to connect silicon ...

Nvidia expands BioNeMo for AI drug discovery with new models, tools, and lab partnerships to automate experiments and speed ...

Autonomy, by contrast, is about decision‑making and adaptation. The leap from automation to autonomy is not just more actuators; it is a system that can perceive its environment, reason about options, ...

Explore the impact of drug discovery automation in 2026, addressing complexity and improving decision-making across ...

Nvidia CEO Jensen Huang declared physical AI as enabling “a new era of AI,” a bold proclamation now backed by concrete technological breakthroughs. Nvidia’s vision extends beyond isolated automation ...

Key market opportunities in the electronic lab notebook AI segment include increased demand for real-time tracking, ...

Wayne State University, a premier urban public research institution, and Kyndryl (NYSE: KD), a leading provider of ...

Wayne State University announced Tuesday that it’s partnering with Kyndryl, an IBM spinoff IT infrastructure services ...